ArticleUrolithiasis2025
Symptomatic urinary stone disease in Kazakhstan: hospitalization trends from the national electronic healthcare system (2014-2021).
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and burden of urolithiasis in China, 1990-2021: a systematic analysis of the global burden of disease study 2021 with future projections to 2036.World journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the prevalence and trends of USD in Kazakhstan using retrospective data from the Unified National Electronic Health System (UNEHS), spanning from 2014 to 2021. Urinary stone disease (USD), a prevalent urological condition globally, is characterized by the formation of stones in any part of the urinary tract, including the kidneys, ureters, bladder, or urethra. A total of 162,538 hospitalization records from 132,915 patients diagnosed with urolithiasis were analyzed. The study reveals an overall hospitalization prevalence of 1.31 per 1,000 individuals, with the highest rates observed in the southern regions, including Turkestan and Almaty, which align with the geographical characteristics of the "stone belt." Demographic data show a predominance of hospitalizations among individuals aged 50 and above, with a near-equal gender distribution, reflecting a global trend of increasing USD prevalence in women. The urban-rural disparity in hospitalization rates highlights a higher burden in urban areas, potentially due to lifestyle and healthcare access factors. Surgical interventions, particularly ureteral and kidney surgeries, were most frequently performed in urban hospitals. Despite significant healthcare improvements, the study underscores the need for more detailed epidemiological data on USD in Kazakhstan, emphasizing regional, environmental, and socioeconomic factors. The findings provide critical insights for public health strategies and resource allocation aimed at addressing the growing burden of USD in Kazakhstan.
Indexed as
Identifiers
40542860What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.